• 先進医療研究開発部
• 幹細胞医療研究室
• 再生医療研究室
• 分子医療研究室
• Bi-AMPS
• 業績
  プレスリリース
• 関連リンク
• TOP

プレスリリース

脳型ドレブリンを指標としたヒトiPS細胞由来神経細胞のシナプス成熟評価法の開発とシナプス形成過程の解明

英文業績

①原著論文

1. Mitobe Y, Kamimura S, Nakamura K, Kanemura Y, Hiraka T, Kanoto M, Sonoda Y: Prognostic impact of RANO resect group classification post-chemoradiotherapy in IDH-wildtype glioblastoma. J Neurooncol. 2026 Jul 31;179(1):23. doi: 10.1007/s11060-026-05731-z. PMID: 42538484
2. Sugai K, Tsuji O, Fujiyoshi K, Ozaki M, Abe T, Kohzuki T, Okawara H, Sawada T, Sumida M, Yoshioka E, Shofuda T, Kawashima S, Yamaguchi R, Shinozaki M, Takasu N, Nagoshi N, Okubo T, Kohyama J, Maeda T, Yato Y, Kanemura Y, Yamanaka S, Nakamura M, Okano H: An iPSC-derived neural progenitor cell therapy for subacute spinal cord injury: a phase 1 trial with long-term follow-up. Nat Med. 2026 Jul 21. doi: 10.1038/s41591-026-04549-6. Online ahead of print.
3. Yokoyama S, Joo T, Sato T, Matsumura S, Tamiya M, Shimomura K, Ito Y, Takenaka R, Hariki R, Kanemura Y: Rectal transection by pushing method using the rectum holding forceps during laparoscopic anterior resection. Asian J Endosc Surg. 2026 June 25. doi: 10.1111/ases.70336. Online ahead of print.
4. Go K, Katsuma A, Yoshioka E, Shofuda T, Fukuoka K, Ichimura K, Matsushita Y, Mineharu Y, Makino Y, Kawauchi T, Sasaki A, Hirato J, Inoue T, Kodama Y, Mano M, Kanematsu D, Kijima N, Kagawa N, Keino D, Mukasa A, Suzuki T, Yoshimoto K, Kuga D, Horiguchi K, Yamaguchi S, Kanamori M, Yamasaki K, Ishibashi K, Akai T, Yamaoka M, Ishizaki R, Kawamura A, Ohba S, Ishida J, Ando R, Fukai J, Miwa T, Fujii M, Muroi A, Saito K, Harada A, Hayashi Y, Nonaka M, Park YS, Kobayashi Y, Higuchi T, Miyairi Y, Yoshifuji K, Takebe N, Oya S, Nakajo K, Nakada M, Nakano Y, Kambara M, Adachi K, Tanaka K, Nakamura H, Sonoda Y, Saito R, Wataya T, Kurozumi K, Taylor MD, Narita Y, Shibui S, Arai H, Sakamoto H, Date I, Nagane M, Nishikawa R, Arakawa Y, Kanemura Y: Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods. Brain Pathol 36(3):e70092, 2026
5. Nakano Y, Hirato J, Yoshioka T, Takimoto T, Nobusawa S, Satomi K, Tomomasa R, Yamada S, Homma T, Sasaki S, Yamazaki A, Sakaguchi M, Takeuchi Y, Fukazawa N, Yamasaki K, Fukuoka K, Kimura YS, Nagayama Y, Inoue Y, Miyahira A, Yoshioka E, Katsuma A, Fukusumi H, Shofuda T, Hibiya Y, Matsushita Y, Kitahara MH, Yomoda Y, Kato M, Taylor MD, Arai Y, Shibata T, Sakamoto H, Terashima K, Arakawa Y, Kumabe T, Nishikawa R, Hara J, Kanemura Y, Ichimura K: A Nationwide Central Diagnosis for Pediatric CNS Tumors in Japan: The JCCG Brain Tumor and Pathology Committees. Cancer Sci 117:1975-1984, 2026
6. Richardson S, Hicks D, Gough M, Butler ER, Thompson D, Castle J, Crosier S, Garcia-Ariza M, Martín-Guerrero I, Plasschaert S, Bourdeaut F, Dufour C, Masliah-Planchon J, Buttarelli FR, Biassoni V, Massimino M, Ichimura K, Kanemura Y, Ramaswamy V, Gajjar A, Mynarek M, Rutkowski S, Kool M, Pfister SM, Korshunov A, Schwalbe EC, Bailey S, Clifford SC: Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study. Lancet Child Adolesc Health 10:491-504, 2026
7. Richardson S, Hicks D, Gough M, Butler ER, Thompson D, Castle J, Crosier S, Garcia-Ariza M, Martín-Guerrero I, Plasschaert SLA, Bourdeaut F, Dufour C, Masliah-Planchon J, Buttarelli FR, Biassoni V, Massimino M, Ichimura K, Kanemura Y, Ramaswamy V, Gajjar A, Kool M, Korshunov A, Pfister SM, Mynarek M, Rutkowski S, Schwalbe EC, Bailey S, Clifford SC: Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study. EClinicalMedicine 96:103913, 2026
8. Takahashi S, Takahashi M, Kinoshita M, Miyake M, Kawaguchi R, Shinojima N, Mukasa A, Saito K, Nagane M, Otani R, Higuchi F, Tanaka S, Hata N, Tamura K, Tateishi K, Nishikawa R, Arita H, Nonaka M, Uda T, Fukai J, Okita Y, Tsuyuguchi N, Kanemura Y, Tsushima F, Kakeda S, Akashi T, Taoka T, Watanabe Y, Yamada K, Hirai T, Azuma M, Yoshiura T, Sese J, Ichimura K, Narita Y, Hamamoto R: Comparing artificial intelligence and physician performance in predicting IDH mutation status in glioma. NPJ Digit Med 9:528, 2026
9. Katsuma A, Kanematsu D, Handa Y, Shofuda T, Yamamoto A, Nishitani K, Xiao Z, Kawauchi D, Baba K, Inagaki N, Kanemura Y: L1CAM Promotes the Infiltrative Properties of Patient-Derived Glioblastoma Cells. Cancer Sci 117:1380-1396, 2026
10. Fujimi Y, Asai K, Watanabe D, Uehira T, Kanemura Y, Izutsu N, Kawabata S, Kuroda H, Kida M, Kanechi M, Okusu K, Nishijima Y, Matsumoto T, Fujinaka T: Brain Lesions Associated with Human Immunodeficiency Virus Infection in the Antiretroviral Therapy Era: A Single-center Experience in Japan. Neurol Med Chir (Tokyo) 66:233-239, 2026
11. Hägg A, Wood R, Mochizuki AL, Abberton K, Abranches E, Alvarez-Palomo B, Baptista R, Quintanilha Barbosa RA, Barry J, Carvalho AB, Bennaceur Griscelli A, Campos de Carvalho AC, Chaker D, Chang H, Choi HY, Codinach M, Arán Corbella B, Cowan S, Dickerson SJ, Elwood N, Fan X, Feyeux M, Forrester M, Gaffney A, Guilbert SM, Ha HY, Hirst AJ, Hunter AL, Jamieson LG, Judson RN, Kanemura Y, Kasai-Brunswick TH, Kim JH, Kim H, Kintali M, Krishnan S, Kuebler B, Lau CY, Li W, Mack A, MacLeod MR, Madrid M, Mamiya H, Manache-Alberici L, Mărginean D, Mentre O, Morgan SL, Mountford J, Munir H, Ng SHS, Ogawa H, Oh S, Ohara H, Oono K, Park N, Pereira LV, Pereira da Silva Bezerra I, Podovei AR, Querol S, Raje J, Raya A, Sakamoto S, Sarafian R, Schmit K, Selvitella S, Singh G, Smart MJK, Song J, Stacey G, Sullivan S, Sumida M, Terrenoire C, Tian P, Uhlin E, Vaquero JMA, Veiga A, Vicky Wang JW, Warre-Cornish K, Wood J, Yamamoto A, Zhang G, Hikichi T, Turner M, Falk A. Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment Round. Stem Cell Reports 21:102857, 2026
12. Arita H, Hirai K, Sakai M, Hagioka T, Takano K, Umehara T, Yoshizawa H, Kodama Y, Kashiwagi N, Nakanishi K, Kanemura Y: Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas. Brain Tumor Pathol 43:56-64, 2026
13. Umehara T, Kinoshita M, Sasaki T, Fukai J, Yoshioka E, Sakamoto D, Nakajo K, Takano K, Arita H, Yokota C, Hirayama R, Kijima N, Okita Y, Kishima H, Kanemura Y: Radiomics-based preoperative survival prediction in newly diagnosed glioblastoma: A multicohort study with internal and external validation. Neurooncol Adv 8:vdag068, 2026
14. Arakawa Y, Saito R, Kanemura Y, Mishima K, Koriyama S, Narita Y, Kumabe T, Motomura K, Sugiyama K, Yamasaki F, Mukasa A, Kanamori M, Kuga D, Nagane M, Kakurai Y, Isobe K, Nakamura H: Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas. Neuro Oncol 28:717-727, 2026
15. Sanada T, Shimizu T, Okita Y, Arita H, Sato H, Saito M, Mitsui N, Hiroshima S, Isohashi K, Tanino M, Kanemura Y, Kishima H, Kinoshita M: Radiomics Analysis of Non-Enhancing Lesions After Bevacizumab Administration in Recurrent Glioblastoma. Bioengineering (Basel) 13:28, 2025
16. Nakatogawa H, Fukai J, Kawaji H, Hayashi N, Yoshioka E, Kodama Y, Nakajo K, Uda T, Arakawa Y, Takada S, Kijima N, Ishibashi K, Okuda T, Sonoda Y, Ohue S, Arita H, Matsuda M, Fukami T, Tomita T, Inoue A, Achiha T, Kashiwagi H, Kanematsu D, Katsuma A, Sumida M, Shofuda T, Mano M, Kinoshita M, Mori K, Inenaga C, Kanemura Y: Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort study. Acta Neuropathol Commun 13:77, 2025
17. Baba K, Fukushi-Kumagai A, Morisaki M, Takeuchi R, Xiao Z, Nagashima Y, Sakai M, Higashiguchi Y, Katsuno-Kambe H, Katsuma A, Ueda Y, Kamioka Y, Kawauchi D, Kinashi T, Kanemura Y, Inagaki N: Weak and Tunable Adhesion-Clutch Drives Rapid Cell Migration and Glioblastoma Invasion. Adv Sci (Weinh). 12:e02074, 2025
18. Nakashima T, Miyauchi T, Takeuchi R, Sugihara Y, Funakoshi Y, Ohka F, Maeda S, Hirato J, Yoshioka T, Okita H, Narita Y, Kanemura Y, Kojima Y, Watanabe Y, Saito R, Suzuki H: Diversity of U1 Small Nuclear RNAs and Diagnostic Methods for Their Mutations. Cancer Sci 116:2270-2280, 2025
19. Kobayashi K, Kidani T, Nakajima S, Kanemura Y, Asai K, Izutsu N, Kawamoto S, Nishizawa N, Nomoto M, Fujimi Y, Kida M, Fujinaka T: Endovascular Treatment for Traumatic Carotid Cavernous Fistula: Case Series. J Neuroendovasc Ther 19:2024-0111, 2025
20. Nishizawa N, Ozaki T, Kidani T, Izutsu N, Nakajima S, Kanemura Y, Fujinaka T: The Feasibility of Early Shunting for Hydrocephalus after Subarachnoid Hemorrhage. Neurol Med Chir (Tokyo) 65:177-185, 2025
21. Murakami K, Kidani T, Nakajima S, Kanemura Y, Ozaki T, Asai K, Izutsu N, Kobayashi H, Fujimi Y, Fujinaka T: Effectiveness of Surgical Excision in Preventing Recurrence of Multilocular Brain Abscess. Cureus 17:e80105, 2025
22. Chida D, Okita Y, Utsugi R, Kuroda H, Hirayama R, Kijima N, Arisawa A, Kagawa N, Kanemura Y, Yoshimura S, Tomiyama N, Kishima H: Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting MGMT promoter methylation and prognostic value in newly diagnosed patients with glioblastoma. Oncol Lett 28:610, 2024
23. Sanada T, Kinoshita M, Sasaki T, Yamamoto S, Fujikawa S, Fukuyama S, Hayashi N, Fukai J, Okita Y, Nonaka M, Uda T, Arita H, Mori K, Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu D, Tanino M, Kodama Y, Mano M, Kanemura Y: Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity image. Neurooncol Adv 6:vdae016, 2024
24. Kawamoto S, Ozaki T, Asai K, Kidani T, Izutsu N, Nakajima S, Kanemura Y, Nishizawa N, Kobayashi K, Fujimi Y, Fujinaka T: Treatment Outcomes of PED for Unruptured Aneurysms of Internal Carotid Artery: Comparison of PED-Flex and PED-Shield. Neurol Med Chir (Tokyo) 64: 316-322, 2024
25. Watanabe D, Okamoto N, Kobayashi Y, Suzuki H, Kato M, Saitoh S, Kanemura Y, Takenouchi T, Yamada M, Nakato D, Sato M, Tsunoda T, Kosaki K, Miya F: Biallelic structural variants in three patients with ERCC8-related Cockayne syndrome and a potential pitfall of copy number variation analysis. Sci Rep 14:19741, 2024
26. Hayashi N, Fukai J, Nakatogawa H, Kawaji H, Yoshioka E, Kodama Y, Nakajo K, Uda T, Naito K, Kijima N, Okita Y, Kagawa N, Takahashi Y, Hashimoto N, Arita H, Takano K, Sakamoto D, Iida T, Arakawa Y, Kawauchi T, Sonoda Y, Mitobe Y, Ishibashi K, Matsuda M, Achiha T, Tomita T, Nonaka M, Hara K, Takebe N, Tsuzuki T, Nakajima Y, Ohue S, Nakajima N, Watanabe A, Inoue A, Umegaki M, Kanematsu D, Katsuma A, Sumida M, Shofuda T, Mano M, Kinoshita M, Mori K, Nakao N, Kanemura Y: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort. Acta Neuropathol Commun 12:120, 2024
27. Nomoto M, Kidani T, Kida M, Kobayashi K, Fujimi Y, Kawamoto S, Izutsu N, Asai K, Kanemura Y, Nakajima S, Fujinaka T: Treatment Outcomes in Patients with Unruptured Anterior Choroidal Artery Aneurysms: A Single-Center Experience. J Neuroendovasc Ther 18:219-223, 2024
28. Kanemura Y, Yamamoto A, Katsuma A, Fukusumi H, Shofuda T, Kanematsu D, Handa Y, Sumida M, Yoshioka E, Mine Y, Yamaguchi R, Okada M, Igarashi M, Sekino Y, Shirao T, Nakamura M, Okano H: Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains. Cells 13:671, 2024
29. Kamimura S, Mitobe Y, Nakamura K, Matsuda K, Kanemura Y, Kanoto M, Futakuchi M, Sonoda Y: Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild type. Surg Neurol Int 15:108, 2024
30. Fukuoka K, Kurihara J, Shofuda T, Kagawa N, Yamasaki K, Ando R, Ishida J, Kanamori M, Kawamura A, Park YS, Kiyotani C, Akai T, Keino D, Miyairi Y, Sasaki A, Hirato J, Inoue T, Nakazawa A, Koh K, Nishikawa R, Date I, Nagane M, Ichimura K, Kanemura Y: Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study. Acta Neuropathol Commun 11:153, 2023
31. Kidani T, Ozaki T, Nakajima S, Kanemura Y, Izutsu N, Kawamoto S, Taki K, Murakami K, Nishizawa N, Kobayashi K, Fujimi Y, Fujinaka T: Predictors of middle meningeal artery-related vascular diseases associated with blunt head trauma. World Neurosurg 180:e667-e675, 2023
32. Nishimoto K, Ozaki T, Kidani T, Nakajima S, Kanemura Y, Yamazaki H, Fujinaka T: Flow Diverter Stenting for Symptomatic Intracranial Internal Carotid Artery Aneurysms: Clinical Outcomes and Factors for Symptom Improvement. Neurol Med Chir (Tokyo) 63:343-349, 2023
33. Fukusumi H, Togo K, Beck G, Shofuda T, Kanematsu D, Yamamoto A, Sumida M, Baba K, Mochizuki H, Kanemura Y: Human induced pluripotent stem cell line (ONHi001-A) generated from a patient with infantile neuroaxonal dystrophy having PLA2G6 c.517C > T (p.Q173X) and c.1634A > G (p.K545R) compound heterozygous mutations. Stem Cell Res 69:103122, 2023
34. Nakagawa T, Kijima N, Hasegawa K, Ikeda S, Yaga M, Wibowo T, Tachi T, Kuroda H, Hirayama R, Okita Y, Kinoshita M, Kagawa N, Kanemura Y, Hosen N, Kishima H: Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy. Neurooncol Adv 5:vdac177, 2022
35. Nakamura Y, Inoue A, Nishikawa M, Ohnishi T, Yano H, Kanemura Y, Ohtsuka Y, Ozaki S, Kusakabe K, Suehiro S, Yamashita D, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T: Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy. Acta Neurochir (Wien) 164:3253-3266, 2022
36. Sanada T, Yamamoto S, Sakai M, Umehara T, Sato H, Saito M, Mitsui N, Hiroshima S, Anei R, Kanemura Y, Tanino M, Nakanishi K, Kishima H, Kinoshita M: Correlation of T1- to T2-weighted signal intensity ratio with T1- and T2-relaxation time and IDH mutation status in glioma. Sci Rep 12:18801, 2022
37. Yamazaki H, Fujinaka T, Ozaki T, Kidani T, Nishimoto K, Taki K, Nishizawa N, Murakami K, Kanemura Y, Nakajima S: Staged treatment for ruptured wide-neck intracranial aneurysm with intentional partial coiling in the acute phase followed by definitive treatment. Surg Neurol Int 13:322, 2022
38. Okada M, Kawagoe Y, Takasugi T, Nozumi M, Ito Y, Fukusumi H, Kanemura Y, Fujii Y, Igarashi M: JNK1‑Dependent Phosphorylation of GAP‑43 Serine 142 is a Novel Molecular Marker for Axonal Growth. Neurochem Res 47:2668-2682, 2022
39. Yamamoto T, Sato Y, Yasuda S, Shikamura M, Tamura T, Takenaka C, Takasu N, Nomura M, Dohi H, Takahashi M, Mandai M, Kanemura Y, Nakamura M, Okano H, Kawamata S: Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests. Stem Cells Transl Med 11:527-538, 2022
40. Ozaki T, Fujinaka T, Kidani T, Nishimoto K, Yamazaki H, Sawada H, Taki K, Kanemura Y, Nakajima S: Coil Embolization of Unruptured Cerebral Aneurysms Using Stents in Small Arteries Less Than 2 mm in Diameter. Neurosurgery 90:538-546, 2022
41. Matsuda K, Kokubo Y, Kanemura Y, Kanoto M, Sonoda Y: Preoperative Apparent Diffusion Coefficient of Peritumoral Lesion Associate with Recurrence in Patients with Glioblastoma. Neurol Med Chir (Tokyo) 62:28-34, 2022
42. Nakajo K, Uda T, Kawashima T, Terakawa Y, Ishibashi K, Tsuyuguchi N, Tanoue Y, Nagahama A, Uda H, Koh S, Sasaki T, Ohata K, Kanemura Y, Goto T: Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma. Sci Rep 12:546, 2022
43. Yamamoto S, Sanada T, Sakai M, Arisawa A, Kagawa N, Shimosegawa E, Nakanishi K, Kanemura Y, Kinoshita M, Kishima H: Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map. Brain Sci 12:99, 2022
44. Togo K, Fukusumi H, Shofuda T, Ohnishi H, Yamazaki H, Hayashi MK, Kawasaki N, Takei N, Nakazawa T, Saito Y, Baba K, Hashimoto H, Sekino Y, Shirao T, Mochizuki H, Kanemura Y: Postsynaptic structure formation of human iPS cell-derived neurons takes longer than presynaptic formation during neural differentiation in vitro. Mol Brain 14:149, 2021
45. Makino Y, Arakawa Y, Yoshioka E, Shofuda T, Minamiguchi S, Kawauchi T, Tanji M, Kanematsu D, Nonaka M, Okita Y, Kodama Y, Mano M, Hirose T, Mineharu Y, Miyamoto S, Kanemura Y: Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC Cancer 21:1025, 2021
46. Sugai K, Sumida M, Shofuda T, Yamaguchi R, Tamura T, Kohzuki T, Abe T, Shibata R, Kamata Y, Ito S, Okubo T, Tsuji O, Nori S, Nagoshi N, Yamanaka S, Kawamata S, Kanemura Y, Nakamura M, Okano H: First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol. Regen Ther 18:321-333, 2021
47. Takami H, Satomi K, Fukuoka K, Fukushima S, Matsushita Y, Yamasaki K, Nakamura T, Tanaka S, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K: Low tumor cell content predicts favorable prognosis in germinoma patients. Neurooncol Adv 3:vdab110, 2021
48. Kinoshita M, Uchikoshi M, Tateishi S, Miyazaki S, Sakai M, Ozaki T, Asai K, Fujita Y, Matsuhashi T, Kanemura Y, Shimosegawa E, Hatazawa J, Nakatsuka SI, Kishima H, Nakanishi K: Magnetic Resonance Relaxometry for Tumor Cell Density Imaging for Glioma: An Exploratory Study via 11C-Methionine PET and Its Validation via Stereotactic Tissue Sampling. Cancers (Basel) 13:4067, 2021
49. Fujimoto K, Arita H, Satomi K, Yamasaki K, Matsushita Y, Nakamura T, Miyakita Y, Umehara T, Kobayashi K, Tamura K, Tanaka S, Higuchi F, Okita Y, Kanemura Y, Fukai J, Sakamoto D, Uda T, Machida R, Kuchiba A, Maehara T, Nagane M, Nishikawa R, Suzuki H, Shibuya M, Komori T, Narita Y, Ichimura K: TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol 142:323-338, 2021
50. Makino Y, Arakawa Y, Yoshioka E, Shofuda T, Kawauchi T, Terada Y, Tanji M, Kanematsu D, Mineharu Y, Miyamoto S, Kanemura Y: Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA. Sci Rep 11:14408, 2021
51. Inoue A, Nishikawa M, Ohnishi T, Yano H, Kanemura Y, Ohtsuka Y, Ozaki S, Nakamura Y, Matsumoto S, Suehiro S, Yamashita D, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T: Prediction of glioma stem-like cell infiltration in the non-contrast-enhancing area by quantitative measurement of lactate on magnetic resonance spectroscopy in glioblastoma. World Neurosurg 153:e76-e95, 2021
52. Nishikawa M, Inoue A, Ohnishi T, Yano H, Ozaki S, Kanemura Y, Suehiro S, Ohtsuka Y, Kohno S, Ohue S, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T: Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma. Transl Oncol 14:101137, 2021
53. Anami S, Fukai J, Hama M, Awaya A, Inagaki T, Chiba T, Noda Y, Kanemura Y, Nakao N, Sonomura T: Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy. Anticancer Res 41:2583-2589, 2021
54. Okada M, Kawagoe Y, Sato Y, Nozumi M, Ishikawa Y, Tamada A, Yamazaki H, Sekino Y, Kanemura Y, Shinmyo Y, Kawasaki H, Kaneko N, Sawamoto K, Fujii Y, Igarashi M: Phosphorylation of GAP-43 T172 is a molecular marker of growing axons in a wide range of mammals including primates. Mol Brain 14:66, 2021
55. Miyahara H, Natsumeda M, Kanemura Y, Yamasaki K, Riku Y, Akagi A, Oohashi W, Shofuda T, Yoshioka E, Sato Y, Taga T, Naruke Y, Ando R, Hasegawa D, Yoshida M, Sakaida T, Okada N, Watanabe H, Ozeki M, Arakawa Y, Yoshimura J, Fujii Y, Suenobu S, Ihara K, Hara J, Kakita A, Yoshida M, Iwasaki Y: Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children's Cancer Group. Brain Tumor Pathol 38:109-121, 2021
56. Takahashi S, Takahashi M, Kinoshita M, Miyake M, Kawaguchi R, Shinojima N, Mukasa A, Saito K, Nagane M, Otani R, Higuchi F, Tanaka S, Hata N, Tamura K, Tateishi K, Nishikawa R, Arita H, Nonaka M, Uda T, Fukai J, Okita Y, Tsuyuguchi N, Kanemura Y, Kobayashi K, Sese J, Ichimura K, Narita Y, Hamamoto R: Fine- Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among Facilities. Cancers (Basel). 13:1415, 2021
57. Ito N, Riyadh MA, Ahmad SAI, Hattori S, Kanemura Y, Kiyonari H, Abe T, Furuta Y, Shinmyo Y, Kaneko N, Hirota Y, Lupo G, Hatakeyama J, Abdulhaleem M FA, Anam MB, Yamaguchi M, Takeo T, Takebayashi H, Takebayashi M, Oike Y, Nakagata N, Shimamura K, Holtzman MJ, Takahashi Y, Guillemot F, Miyakawa T, Sawamoto K, Ohta K: Dysfunction of the proteoglycan Tsukushi causes hydrocephalus through altered neurogenesis in the subventricular zone in mice. Sci Transl Med 13:eaay7896, 2021
58. Nakajo K, Uda T, Kawashima T, Terakawa Y, Ishibashi K, Tsuyuguchi N, Tanoue Y, Nagahama A, Uda H, Koh S, Sasaki T, Ohata K, Kanemura Y, Goto T: Diagnostic Performance of [11C]Methionine Positron Emission Tomography in Newly Diagnosed and Untreated Glioma Based on the Revised World Health Organization 2016 Classification. World Neurosurg S1878-8750:00033-4, 2021
59. Kinoshita M, Arita H, Takahashi M, Uda T, Fukai J, Ishibashi K, Kijima N, Hirayama R, Sakai M, Arisawa A, Takahashi H, Nakanishi K, Kagawa N, Ichimura K, Kanemura Y, Narita Y, Kishima H: Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas. Front Oncol 10:596448, 2021
60. Nishikawa M, Inoue A, Ohnishi T, Yano H, Kanemura Y, Kohno S, Ohue S, Ozaki S, Matsumoto S, Suehiro S, Nakamura Y, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T: CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma. Cancer Med 10:2013-2025, 2021
61. Fukusumi H, Togo K, Sumida M, Nakamori M, Obika S, Baba K, Shofuda T, Ito D, Okano H, Mochizuki H, Kanemura Y: Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication. FEBS Open Bio 11: 354-366, 2021
62. Itai T, Miyatake S, Taguri M, Nozaki F, Ohta M, Osaka H, Morimoto M, Tandou T, Nohara F, Takami Y, Yoshioka F, Shimokawa S, Okuno-Yuguchi J, Motobayashi M, Takei Y, Fukuyama T, Kumada S, Miyata Y, Ogawa C, Maki Y, Togashi N, Ishikura T, Kinoshita M, Mitani Y, Kanemura Y, Omi T, Ando N, Hattori A, Saitoh S, Kitai Y, Hirai S, Arai H, Ishida F, Taniguchi H, Kitabatake Y, Ozono K, Nabatame S, Smigiel R, Kato M, Tanda K, Saito Y, Ishiyama A, Noguchi Y, Miura M, Nakano T, Hirano K, Honda R, Kuki I, Takanashi JI, Takeuchi A, Fukasawa T, Seiwa C, Harada A, Yachi Y, Higashiyama H, Terashima H, Kumagai T, Hada S, Abe Y, Miyagi E, Uchiyama Y, Fujita A, Imagawa E, Azuma Y, Hamanaka K, Koshimizu E, Mitsuhashi S, Mizuguchi T, Takata A, Miyake N, Tsurusaki Y, Doi H, Nakashima M, Saitsu H, Matsumoto N: Prenatal clinical manifestations in individuals with COL4A1/2 variants. J Med Genet 58:505-513, 2021
63. Kinoshita M, Uchikoshi M, Sakai M, Kanemura Y, Kishima H, Nakanishi K: T2-FLAIR Mismatch Sign Is Caused by Long T1 and T2 of IDH-mutant, 1p19q Non-codeleted Astrocytoma. Magn Reson Med Sci 20:119-123, 2021
64. Achiha T, Kijima N, Kodama Y, Kagawa N, Kinoshita M, Fujimoto Y, Nonaka M, Fukai J, Inoue A, Nishida N, Yamanaka T, Harada A, Mori K, Tsuyuguchi N, Uda T, Ishibashi K, Tomogane Y, Sakamoto D, Shofuda T, Yoshioka E, Kanematsu D, Mano M, Luu B, Taylor MD, Kanemura Y, Kishima H: Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion. PLoS One 15:e0243272, 2020
65. Arita H, Matsushita Y, Machida R, Yamasaki K, Hata N, Ohno M, Yamaguchi S, Sasayama T, Tanaka S, Higuchi F, Iuchi T, Saito K, Kanamori M, Matsuda KI, Miyake Y, Tamura K, Tamai S, Nakamura T, Uda T, Okita Y, Fukai J, Sakamoto D, Hattori Y, Pareira ES, Hatae R, Ishi Y, Miyakita Y, Tanaka K, Takayanagi S, Otani R, Sakaida T, Kobayashi K, Saito R, Kurozumi K, Shofuda T, Nonaka M, Suzuki H, Shibuya M, Komori T, Sasaki H, Mizoguchi M, Kishima H, Nakada M, Sonoda Y, Tominaga T, Nagane M, Nishikawa R, Kanemura Y, Kuchiba A, Narita Y, Ichimura K: TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathol Commun 8:201, 2020
66. Kikuchi Z, Shibahara I, Yamaki T, Yoshioka E, Shofuda T, Ohe R, Matsuda KI, Saito R, Kanamori M, Kanemura Y, Kumabe T, Tominaga T, Sonoda Y: TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neurooncol Adv 2:vdaa114, 2020
67. Okita Y, Shofuda T, Kanematsu D, Yoshioka E, Kodama Y, Mano M, Kinoshita M, Nonaka M, Fujinaka T, Kanemura Y: The association between 11 C-methionine uptake, IDH gene mutation, and MGMT promoter methylation in patients with grade II and III gliomas. Clin Radiol 75:622-628, 2020
68. Fukai J, Arita H, Umehara T, Yoshioka E, Shofuda T, Kanematsu D, Kodama Y, Mano M, Kinoshita M, Okita Y, Nonaka M, Uda T, Tsuyuguchi N, Sakamoto D, Uematsu Y, Nakao N, Mori K, Kanemura Y: Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort. Brain Tumor Pathol 37:50-59, 2020
69. Takami H, Fukushima S, Aoki K, Satomi K, Narumi K, Hama N, Matsushita Y, Fukuoka K, Yamasaki K, Nakamura T, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T, Ueki K, Narita Y, Shibui S, Totoki Y, Shibata T, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K; Intracranial Germ Cell Tumor Genome Analysis Consortium (the iGCT Consortium): Intratumoural Immune Cell Landscape in Germinoma Reveals Multipotent Lineages and Exhibits Prognostic Significance. Neuropathol Appl Neurobiol 46:111-124, 2020
70. Yamaki T, Shibahra I, Matsuda KI, Kanemura Y, Konta T, Kanamori M, Yamakawa M, Tominaga T, Sonoda Y: Relationships between recurrence patterns and subventricular zone involvement or CD133 expression in glioblastoma. J Neurooncol 146:489-499, 2020

②症例報告

1. Fukuoka K, Irikura T, Kanemura Y, Hirato J, Yoshioka T, Tanami Y, Kurihara J, Kobayashi M, Oya S, Arakawa Y, Nakazawa A, Koh K: Intratumoral heterogeneity of MYC status and methylation subtyping in group 3 medulloblastoma: A case report. J Neuropathol Exp Neurol. 2025 Dec 23:nlaf153. doi: 10.1093/jnen/nlaf153. Online ahead of print.
2. Ishikawa T, Fukuoka K, Oba D, Ichimura K, Kanemura Y, Tanami Y, Ohashi H, Nakazawa A, Kurihara J, Koh K: Cerebellopontine angle SHH-activated embryonal tumor without interaction from the cerebellum in a patient with Cowden syndrome: A case report. J Neuropathol Exp Neurol 85:206-208, 2026
3. Ito R, Kanamori M, Shimoda Y, Irie M, Niizuma H, Watanabe H, Watanabe M, Kanemura Y, Kikuchi A, Endo H: Hypercalcemia associated with relapsed medulloblastoma due to bone metastasis: illustrative case. J Neurosurg Case Lessons 10:CASE25318, 2025
4. Ikemachi R, Tomita Y, Otani Y, Ishida J, Fujii K, Higaki F, Ono S, Kanemura Y, Tanaka S: A Rare Case of Adult-onset Gangliocytoma in the Parietal Lobe: Case Report and Surveillance, Epidemiology, and End Results Registry Data Analysis. NMC Case Rep J 12:153-158, 2025
5. Yuzawa S, Kanemura Y, Hayashi M, Kamikokura Y, Kinoshita M, Tanino M: Diffuse Hemispheric Glioma, H3 G34-Mutant With Prominent Perivascular Invasion in a Middle-Aged Man: A Case Report and Literature Review of Middle-Aged and Elderly Cases. Neuropathology 45:e70022, 2025
6. Uno T, Asai K, Kidani T, Nishijima Y, Matsumoto T, Kida M, Kanechi M, Fujimi Y, Kobayashi K, Kuroda H, Kawabata S, Izutsu N, Kanemura Y, Fujinaka T: Aneurysms Associated with Hyperplastic Anterior Choroidal Arteries: Three Cases with Literature Review. J Neuroendovasc Ther 19:2024-0097, 2025
7. Tajima Y, Yuzawa S, Kanemura Y, Tanino M, Kinoshita M: Diagnosis of Isocitrate Dehydrogenase-Mutant Astrocytoma in the Subcallosal Gyrus Using T2-Fluid-Attenuated Inversion Recovery Mismatch Sign and Quantitative Magnetic Resonance Relaxometry. Cureus 17:e76963, 2025
8. Nishizawa N, Kidani T, Nakajima S, Kanemura Y, Asai K, Izutsu N, Kawamoto S, Kobayashi K, Nomoto M, Fujimi Y, Kida M, Fujinaka T: Coil Embolization of a Ruptured Traumatic Pseudoaneurysm of the Middle Meningeal Artery: A Case Report. NMC Case Report Journal 11:257-262, 2024
9. Izutsu N, Nishizawa N, Nakajima S, Kanemura Y, Ozaki T, Asai K, Kidani T, Kobayashi K, Fujimi Y, Fujinaka T: Extracranial internal carotid artery-dissecting aneurysm having a re-entry tear and causing lower cranial nerve palsies treated with flow-diverting stent: A case report. Surg Neurol Int 15:126, 2024
10. Fujimi Y, Ozaki T, Izutsu N, Nakajima S, Kanemura Y, Kidani T, Kawamoto S, Nishizawa N, Kobayashi K, Fujinaka T: Fungal symptomatic intracranial aneurysm treated with a flow diverting stent: A case report. Surg Neurol Int 15:58, 2024
11. Mizushima M, Okamoto M, Yamaguchi S, Oki S, Motegi H, Sugiyama M, Manabe A, Shimizu A, Nishioka K, Hashimoto T, Hirato J, Kanemura Y, Fujimura M: Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case. J Neurosurg Case Lessons 6: CASE23277, 2023
12. Umehara T, Arita H, Miya F, Achiha T, Shofuda T, Yoshioka E, Kanematsu D, Nakagawa T, Kinoshita M, Kagawa N, Fujimoto Y, Hashimoto N, Kiyokawa H, Morii E, Tsunoda T, Kanemura Y, Kishima H: Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report. Brain Tumor Pathol 39:218-224, 2022
13. Takeuchi H, Takahashi Y, Tanigawa S, Okamoto T, Koddama Y, Shishido-Hara Y, Yoshioka E, Shofuda T, Kanemura Y, Konichi E, Hashimoto N: Genetic Alteration May Proceed with a Histological Change in Glioblastoma: A Report from Initially Diagnosed as Nontumor Lesion Cases. NMC Case Report Journal 9, 199-208, 2022
14. Izumi R, Takahashi H, Kanemura Y, Shofuda T, Yoshioka E, Narumi R, Matsubara S: Adducted thumb may not be mandatory for prenatal diagnosis of X-linked hydrocephalus in early second trimester. Taiwan J Obstet Gynecol 61:353-355, 2022
15. Nishizawa N, Ozaki T, Kidani T, Nakajima S, Kanemura Y, Nishimoto K, Yamazaki H, Mori K, Fujinaka T: Stent infection and pseudoaneurysm formation after carotid artery stent treated by excision and in situ reconstruction with polytetrafluoroethylene graft: A case report. Surg Neurol Int 13:24, 2022
16. Sawada H, Ozaki T, Nakajima S, Kidani T, Kanemura Y, Nishimoto K, Yamazaki H, Taki K, Fujinaka T: Tension pneumocephalus following cranioplasty with a titanium plate: a case report. J Int Med Res 50:3000605221076032, 2022
17. Okamoto N, Miya F, Tsunoda T, Kanemura Y, Saitoh S, Kato M, Yanagi K, Kaname T, Kosaki K: Four pedigrees with aminoacyl-tRNA synthetase abnormalities. Neurol Sci 43:2765-2774, 2022
18. Sano K, Matsuda KI, Kawanami K, Kanemura Y, Ohe R, Sonoda Y: Malignant Progression of an IDH Mutant Brainstem Glioma in Adult. NMC Case Rep J 8:301-307, 2021
19. Okamoto N, Miya F, Kitai Y, Tsunoda T, Kato M, Saitoh S, Kanemura Y, Kosaki K: Homozygous ADCY5 mutation causes early-onset movement disorder with severe intellectual disability. Neurol Sci 42:2975-2978, 2021
20. Kijima N, Miuro S, Terada E, Nakagawa R, Tachi T, Murakami K, Okita Y, Kanemura Y, Nakajima S, Fujinaka T: Endovascular Treatment for Middle Cerebral Artery Aneurysms: Single-Center Experience and Review of Literatures. Journal of Neuroendovascular Therapy 15:213-219, 2021
21. Mitani Y, Fukuoka K, Mori M, Arakawa Y, Matsushita Y, Hibiya Y, Honda S, Kobayashi M, Tanami Y, Kanemura Y, Ichimura K, Nakazawa A, Kurihara J, Koh K: Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis. J Neuropathol Exp Neurol 80:205-207, 2021
22. Li Y, Nonaka M, Kanemura Y, Kodama Y, Mano M, Asai A: A case of medulloblastoma in a patient with fetal ventricular enlargement. Childs Nerv Sys 37:977-982, 2021
23. Miura S, Kijima N, Fujimori N, Nakagawa T, Nakagawa R, Tachi T, Okita Y, Kanemura Y, Nakajima S, Mano M, Kishima H, Ozawa K, Fujinaka T: Surgical Treatment of Brain Metastasis of Extramammary Paget's Disease: A Case Report. NMC Case Rep J 7:189-193, 2020
24. Aoki T, Kishimoto H, Hirato J, Kanemura Y, Mori M, Arakawa Y, Kurihara J, Oguma E, Koh K: A 21-month-old boy with vomiting, gait disturbance, and abnormal ocular alignment. Brain Pathol 30:425-426, 2020
25. Yotsumoto Y, Harada A, Tsugawa J, Ikura Y, Utsunomiya H, Miyatake S, Matsumoto N, Kanemura Y, Hashimoto-Tamaoki T: Infantile macrocephaly and multiple subcutaneous lipomas diagnosed with PTEN hamartoma tumor syndrome. Mol Clin Oncol 12:329-335, 2020

③総説

1. Kinoshita M, Kanemura Y, Narita Y, Kishima H: Reverse Engineering Glioma Radiomics to Conventional Neuroimaging. Neurol Med Chir (Tokyo) 61:505-514, 2021

④著書

1. Yamasaki M, Kanemura Y: X-Linked Hydrocephalus. Textbook of Pediatric Neurosurgery (Editors: Di Rocco, Concezio, Pang, Dachling, Rutka, James T) P.521-531, Springer International Publishing Copyright Holder Springer Nature Switzerland AG, 2020

和文業績

①原著論文

1. 藤見洋佑, 浅井克則, 金村米博, 井筒伸之, 川端修平, 黒田秀樹, 木田将義, 金地真生, 大楠景子, 松本貴晶, 西嶋吉継, 藤中俊之：くも膜下出血の発症日における気象条件の変化 ─体感気温の低下と発症の関連─．脳卒中の外科 54:69-75, 2026
2. 福岡講平，栗原 淳，荒川ゆうき，森麻希子，大嶋宏一，三谷友一，本田 護，松下裕子，日比谷優子，市村香代子，急式政志，本田聡子，金村米博，信澤純人，市村幸一，中澤温子，康 勝好：小児中枢神経腫瘍に対するDNAメチル化解析を用いた分子分類―単施設報告―．日本小児血液・がん学会雑誌 62:52-58, 2025
3. 寺田栄作, 木嶋教行, 村上皓紀, 中川僚太, 館 哲郎, 髙野浩司, 金村米博, 中島 伸, 藤中俊之：PipelineTM Flexを用いて再治療を行った血管内治療後再発内頚動脈瘤の5症例．脳卒中の外科 49:241-246, 2021
4. 木嶋教行, 中川智義, 三浦慎平, 中川僚太, 舘 哲郎, 沖田典子, 金村米博, 中島 伸, 藤中俊之：重症くも膜下出血患者の治療戦略とその転帰．脳卒中の外科 49:98-102, 2021
5. 館 哲郎，藤中俊之, 西本渓佑, 山崎弘輝, 村上皓紀, 高野浩司, 木谷知樹, 金村米博, 中島 伸：症候性内頸動脈瘤に対するPipeline Embolization Deviceの治療成績．脳神経外科ジャーナル29:864-869, 2020

②症例報告

1. 石毛良実, 水戸部祐太, 松田憲一朗, 北岡 匠, 大江倫太郎, 二口 充, 鈴木修平, 吉岡孝志, 金村米博, 園田順彦：ミスマッチ修復遺伝子異常を伴う膠芽腫に対してペムブロリズマブが奏効した1例．脳神経外科速報 34: 624-625, 2024

③総説

1. 金村米博：グリオーマ予後を規定する神経腫瘍相互作用．実験医学 44:2089-2094, 2026
2. 原田敦子，四本由郁，金村米博，玉置知子：先天性小児脳神経外科疾患の遺伝学的診断．脳神経外科ジャーナル 33:331-338, 2024
3. 園田順彦，松田憲一朗，伊藤美以子，齋藤竜太，金森政之，金村米博，冨永悌二：再発小児悪性脳腫瘍に対する手術療法．小児の脳神経48:33-38, 2023
4. 金村米博：脳梗塞の再生医療．再生医療　22:150-155, 2023
5. 金村米博：小児脳腫瘍の分類・診断．脳神経外科51:778-788, 2023
6. 金村米博：Medulloblastoma．Clinical Neuroscience 41:518-522, 2023
7. 金村米博：小児脳腫瘍の分子診断．病理と臨床41:170-176, 2023
8. 木下 学, 金村米博, 成田善孝, 貴島晴彦：神経膠腫の質的診断の進歩―画像と遺伝子―．脳神経外科ジャーナル31:4-10, 2022
9. 金村米博：髄芽腫．脳神経外科 50:73-90, 2022
10. 金村米博：総論　悪性脳腫瘍の基礎から臨床の現状．Medical Science Digest 46:3-5, 2020
11. 金村米博：NHOにおける臨床研究法の取り組みについて－認定臨床研究審査委員会の委員長の立場から－．医療74:283-287, 2020

④著書

1. 金村米博：8章 小児脳神経外科　§3 脳の形成異常　2.大脳皮質形成異常．脳神経外科学第14版（原著　太田富雄、編集　松谷雅生・野崎和彦），P.1099-1110，株式会社金芳堂，2026
2. 金村米博：8章 小児脳神経外科　§3 脳の形成異常　4.後頭蓋窩の脳形成異常、脊髄空洞症　B. Joubert症候群．脳神経外科学第14版（原著　太田富雄、編集　松谷雅生・野崎和彦），P.1119-1120，株式会社金芳堂，2026
3. 金村米博：8章 小児脳神経外科　§7 胎児・新生児期の水頭症　2.遺伝性水頭症．脳神経外科学第14版（原著　太田富雄、編集　松谷雅生・野崎和彦）， P.1184-1186，株式会社金芳堂，2026
4. 福角勇人，金村米博：第2章 スクリーニングのためのヒトiPS細胞由来神経細胞のシナプス成熟度評価法．培養細胞が拓く創薬の今－研究、規制、自動化、そして教育へ－（古江美保　監修），P.17-32，株式会社シーエムシー･リサーチ，2025
5. 金村米博: 各論36　Medulloblastoma,molecularly defined. 脳腫瘍臨床病理カラーアトラス　第5版（日本脳腫瘍病理学会　編），P.103-106，株式会社医学書院，2024
6. 福角勇人，金村米博：6-4　神経幹細胞の培養と分化．細胞培養・組織培養の技術　第4版（日本組織培養学会　編），P.249-253，株式会社朝倉書店，2023
7. 金村米博：11章 先天奇形　§6 原因遺伝子が明らかになった脳神経外科手術の対象になる先天性疾患、§7 遺伝子探索の倫理的問題．脳神経外科学I第13版（原著　太田富雄、編集　松谷雅生・野崎和彦），P.1345-1375，株式会社金芳堂，2021
8. 市村幸一，金村米博：13章 脳腫瘍　§1 総論　11 脳腫瘍遺伝子異常の検査体制．脳神経外科学II第13版（原著　太田富雄、編集　松谷雅生・野崎和彦），P.1568-1572，株式会社金芳堂，2021
9. 金村米博：13章 脳腫瘍　§2 脳腫瘍各論　9 胎児性腫瘍　D.分子4型分類の概略．脳神経外科学II第13版（原著　太田富雄、編集　松谷雅生・野崎和彦），P.1748-1751，株式会社金芳堂，2021
10. 金村米博：小児脳腫瘍における遺伝子異常．脳神経外科速報 2020年増刊　悪性脳腫瘍のすべて－Neuro-Oncologyの教科書－遺伝子診断時代の臨床リアルワールド（杉山一彦，橋本直哉　編集），P. 30-38, 株式会社メディカ出版，2020